跳至主要内容
临床试验/JPRN-UMIN000007520
JPRN-UMIN000007520已完成2 期

Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites. - Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.

The University of Tokyo0 个研究点目标入组 30 人开始时间: 2012年3月21日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with synchronous or metachronous concomitant malignancies 2) Patients with uncontrolled diabetes mellitus 3) Patients with uncontrolled hypertension 4) Patients with renal failure undergoing hemodialysis 5) Patients with prior myocardial infarction or unstable angina within 6 months 6) Patients with liver cirrhosis 7) Patients with intestinal pneumonia, pulmonary fibrosis, and severe pulmonary emphysema 8) Pregnant or lactating female and patients who is considering pregnancy 9) Patients with contraindication for S-1 or paclitaxel 10) Inappropriate patients for entry on this study in the judgement of the investigator

研究者

相似试验